RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
78 hedge funds and large institutions have $546M invested in Revance Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 81 → 78 (-3)
18% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 28
Holders
78
Holding in Top 10
1
Calls
$687K
Puts
$349K
Top Buyers
| 1 | +$42.6M | |
| 2 | +$4.51M | |
| 3 | +$2.94M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.59M |
| 5 |
PC
PointState Capital
New York
|
+$2.11M |
Top Sellers
| 1 | -$6.18M | |
| 2 | -$2.58M | |
| 3 | -$1.91M | |
| 4 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
-$1.51M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.2M |